Baseline characteristics according to age- and sex-adjusted quartiles of plasma adiponectin
| Variables | Adiponectin quartiles | P value | |||
|---|---|---|---|---|---|
| 1 (≤5.13) | 2 (>5.13–7.16) | 3 (>7.16–10.35) | 4 (>10.35) | ||
| Age (years)a | 57 ± 12 | 61 ± 11 | 66 ± 11 | 70 ± 11 | <0.001 |
| Male sex | 93% | 84% | 71% | 49% | <0.001 |
| Hypertension | 26% | 32% | 34% | 36% | 0.27 |
| Current smoking | 58% | 57% | 49% | 45% | 0.05 |
| Hypercholesterolemia | 21% | 16% | 19% | 11% | 0.08 |
| Previous MI | 6% | 5% | 6% | 4% | 0.74 |
| BMI (kg/m2)a | 27.7 ± 4.0 | 27.9 ± 4.6 | 26.1 ± 4.2 | 24.2 ± 4.1 | <0.001 |
| Blood glucose (mmol/L)b | 8.2 (7.0–9.5) | 8.1 (7.2–9.4) | 8.2 (6.8–9.7) | 8.2 (7.0–9.4) | 0.95 |
| Peak TnI (µg/L)b | 100 (26–228) | 94 (28–245) | 83 (32–240) | 134 (26–258) | 0.86 |
| Mid-regional proANP (µmol/L)b | 127 (77–215) | 141 (97–209) | 167 (117–272) | 244 (169–373) | <0.001 |
| CRP (mg/L)b | 3 (2–7) | 3 (2–9) | 4 (1–9) | 4 (1–10) | 0.98 |
| Serum creatinine (µmol/L)b | 95 (82–109) | 91 (79–105) | 91 (77–108) | 89 (73–111) | 0.17 |
| eGFR (mL/min)a | 76 ± 23 | 75 ± 21 | 72 ± 22 | 69 ± 24 | 0.023 |
| Total cholesterol (mmol/L)a | 4.9 ± 1.2 | 4.9 ± 1.1 | 4.9 ± 1.2 | 4.8 ± 1.0 | 0.55 |
| HDL (mmol/L)a | 1.2 ± 0.3 | 1.3 ± 0.3 | 1.4 ± 0.3 | 1.5 ± 0.4 | <0.001 |
| LDL (mmol/L)a | 3.0 ± 1.1 | 3.1 ± 1.0 | 3.0 ± 1.0 | 2.9 ± 1.0 | 0.39 |
| Triglyceride (mmol/L)b | 1.3 (0.9–2.2) | 1.0 (0.7–1.8) | 0.9 (0.6–1.4) | 0.8 (0.6–1.1) | <0.001 |
| Symptom-to-balloon time (min)b | 200 (127–349) | 180 (120–319) | 215 (140–330) | 195 (135–303) | 0.65 |
| Multivessel disease | 23% | 32% | 26% | 25% | 0.83 |
| Culprit lesion | 0.92 | ||||
| Left anterior descending artery | 48% | 47% | 46% | 48% | |
| Circumflex artery | 11% | 14% | 11% | 10% | |
| Right coronary artery | 41% | 39% | 43% | 42% | |
| Glycoprotein IIb/IIIa inhibitor | 28% | 28% | 22% | 22% | 0.52 |